Navigating Early-Stage M&A in Biotech: Challenges and Opportunities

Join us for an insightful panel discussion tailored to early-stage biotech companies and strategic acquirers. Our expert panel will dive into:

• Challenges of M&A when targeting early-stage development companies.
• The critical role of IP and technology transactions in milestone-driven growth.
• Alternative approaches to buying a startup and understanding the unique dynamics of early-stage deals.
• Human Capital and People Ops considerations to identify and retain key talent.

Following the discussion, enjoy cocktails and the opportunity to connect with industry leaders, innovators, and peers.

Don’t miss this opportunity to explore key insights and build connections in the biotech M&A space.